Citation: Th. Maren et al., OCULAR ABSORPTION, BLOOD-LEVELS, AND EXCRETION OF DORZOLAMIDE, A TOPICALLY ACTIVE CARBONIC-ANHYDRASE INHIBITOR, Journal of ocular pharmacology and therapeutics, 13(1), 1997, pp. 23-30
Citation: Th. Maren et al., RENAL AND CEREBROSPINAL-FLUID FORMATION PHARMACOLOGY OF A HIGH-MOLECULAR-WEIGHT CARBONIC-ANHYDRASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 98-104
Citation: Cw. Conroy et al., SYNTHESIS AND PROPERTIES OF 2 NEW MEMBRANE-IMPERMEANT HIGH-MOLECULAR-WEIGHT CARBONIC-ANHYDRASE INHIBITORS, Bioorganic chemistry, 24(3), 1996, pp. 262-272
Authors:
MATSUI H
MURAKAMI M
WYNNS GC
CONROY CW
MEAD A
MAREN TH
SEARS ML
Citation: H. Matsui et al., MEMBRANE CARBONIC-ANHYDRASE(IV) AND CILIARY EPITHELIUM - CARBONIC-ANHYDRASE ACTIVITY IS PRESENT IN THE BASOLATERAL MEMBRANES OF THE NONPIGMENTED CILIARY EPITHELIUM OF RABBIT EYES, Experimental Eye Research, 62(4), 1996, pp. 409-417
Citation: Cw. Conroy et al., CARBONIC-ANHYDRASE INHIBITORS (CAI) DO NOT REACH THE RETINA BY THE TOPICAL ROUTE, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2220-2220